前列腺癌病理学：近期进展与争议
Prostate Cancer Pathology: Recent Updates and Controversies.
作者信息
Sehn Jennifer K
机构信息
Jennifer K. Sehn, MD, is Assistant Professor, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
出版信息
Mo Med. 2018 Mar-Apr;115(2):151-155.
Abstract
Prostate cancer is common, and recent efforts in clinical management have focused on identifying patients who could be candidates from less aggressive management or who could benefit from more aggressive therapy. As prostate cancer histology, especially Gleason score, plays a critical role in predicting patient outcomes, attempts have been made to refine histologic classification and reporting in prostate cancer to facilitate patient risk stratification. This review discusses recent updates in prostate cancer grading and reporting.
摘要
前列腺癌很常见，近期临床管理方面的努力主要集中在识别那些可能适合采用较温和治疗方案的患者，或者那些可能从更积极的治疗中获益的患者。由于前列腺癌组织学，尤其是 Gleason 评分，在预测患者预后方面起着关键作用，因此人们一直在尝试完善前列腺癌的组织学分类和报告，以促进患者风险分层。本综述讨论了前列腺癌分级和报告的最新进展。
相似文献
1
Prostate Cancer Pathology: Recent Updates and Controversies.前列腺癌病理学：近期进展与争议
Mo Med. 2018 Mar-Apr;115(2):151-155.
2
Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.前列腺癌分级：2005年改良版 Gleason 分级系统发布十年后
Arch Pathol Lab Med. 2016 Oct;140(10):1140-52. doi: 10.5858/arpa.2015-0487-SA. Epub 2016 Jan 12.
3
[Prostate cancer. Part 2: Review of the various tumor grading systems over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)].[前列腺癌。第2部分：1966 - 2015年期间各种肿瘤分级系统回顾以及国际泌尿病理学会（ISUP）新分级的未来展望]
Pathologe. 2016 Feb;37(1):11-6. doi: 10.1007/s00292-015-0124-x.
4
Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?多参数磁共振成像能否预测经直肠超声活检结果在更确切组织学检查时的升级？
Urol Oncol. 2014 Aug;32(6):741-7. doi: 10.1016/j.urolonc.2014.01.008. Epub 2014 Jun 26.
5
Prostate cancer grading: recent developments and future directions.前列腺癌分级：最新进展与未来方向。
BJU Int. 2016 Apr;117 Suppl 4:7-8. doi: 10.1111/bju.13467.
6
Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review.中危前列腺癌（Gleason 评分 7，国际泌尿病理学会 Gleason 分组 2-3）患者结局的变异性及其对风险分层的影响：系统评价。
Eur Urol Focus. 2017 Oct;3(4-5):487-497. doi: 10.1016/j.euf.2016.10.010. Epub 2017 Mar 11.
7
Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012.前列腺活检对预测根治性前列腺切除术标本中 Gleason 评分的准确性：2000 - 2012 年全国趋势
BJU Int. 2017 Jan;119(1):50-56. doi: 10.1111/bju.13458. Epub 2016 Mar 24.
8
Recent advances in prostate cancer pathology: Gleason grading and beyond.前列腺癌病理学的最新进展：Gleason分级及其他
Pathol Int. 2016 May;66(5):260-72. doi: 10.1111/pin.12398. Epub 2016 Mar 18.
9
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.2014年国际泌尿病理学会（ISUP）前列腺癌Gleason分级共识会议：分级模式的定义及新分级系统的建议
Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530.
10
Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8.前列腺癌 Gleason 3+5=8 活检诊断结果：与 Gleason 4+4=8 的预后比较
J Urol. 2016 Oct;196(4):1076-81. doi: 10.1016/j.juro.2016.05.105. Epub 2016 Jun 2.
引用本文的文献
1
Neuregulin-1 correlates to early castration-resistant prostate cancer after prostate cancer patients receiving androgen deprivation therapy.在前列腺癌患者接受雄激素剥夺治疗后，神经调节蛋白-1与早期去势抵抗性前列腺癌相关。
J Cancer. 2025 Jul 11;16(10):3261-3269. doi: 10.7150/jca.112954. eCollection 2025.
2
Link between multiple human papillomavirus 16 and 18 infection and prostate cancer, and relevance of tumor characteristics.多种人乳头瘤病毒16型和18型感染与前列腺癌之间的联系以及肿瘤特征的相关性。
Mol Clin Oncol. 2025 Jul 11;23(3):85. doi: 10.3892/mco.2025.2880. eCollection 2025 Sep.
3
Real-world analysis of leuprorelin acetate microspheres-based neoadjuvant therapy for patients with high-risk prostate cancer.基于醋酸亮丙瑞林微球的新辅助治疗对高危前列腺癌患者的真实世界分析。
Front Oncol. 2025 Mar 19;15:1520370. doi: 10.3389/fonc.2025.1520370. eCollection 2025.
4
Machine learning-based identification of high-risk bone metastasis factors after radical prostatectomy in prostate cancer.基于机器学习识别前列腺癌根治术后的高风险骨转移因素
Front Oncol. 2025 Feb 19;15:1549851. doi: 10.3389/fonc.2025.1549851. eCollection 2025.
5
Variables Affecting the Histological Quality of Prostate Core Biopsy Samples in Cancer Detection.癌症检测中影响前列腺穿刺活检样本组织学质量的变量。
J Cancer Biol Res. 2024;11(1). Epub 2024 Feb 29.
6
[Tumor-associated fibroblasts promotes proliferation and migration of prostate cancer cells by suppressing FBXL3 upregulating hsa-miR-18b-5p].肿瘤相关成纤维细胞通过抑制FBXL3上调hsa-miR-18b-5p促进前列腺癌细胞的增殖和迁移。
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1284-1296. doi: 10.12122/j.issn.1673-4254.2024.07.08.
7
Clinical application of serum tumor abnormal protein in prostate cancer patients.血清肿瘤异常蛋白在前列腺癌患者中的临床应用。
BMC Cancer. 2024 May 31;24(1):665. doi: 10.1186/s12885-024-12418-z.
8
A Study of Ki-67 Immunostaining in Prostate Carcinomas and Its Correlation with Gleason's Score and Prognosis: An Experience at a Tertiary Centre in the Himalayan Foothills.前列腺癌中Ki-67免疫染色及其与Gleason评分和预后的相关性研究：喜马拉雅山麓一家三级中心的经验
Indian J Surg Oncol. 2024 Jun;15(2):341-348. doi: 10.1007/s13193-024-01902-4. Epub 2024 Feb 21.
9
Content and tissue expression of Collagen I, Collagen IV, and Laminin in the Extracellular Matrix in Prostate Adenocarcinoma.前列腺腺癌细胞外基质中Ⅰ型胶原、Ⅳ型胶原和层粘连蛋白的含量和组织表达。
J Mol Histol. 2024 Jun;55(3):371-378. doi: 10.1007/s10735-024-10196-3. Epub 2024 May 4.
10
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3.一种编码蛋白质的CCDC7环状RNA通过上调FLRT3抑制前列腺癌进展。
NPJ Precis Oncol. 2024 Jan 16;8(1):11. doi: 10.1038/s41698-024-00503-2.
本文引用的文献
1
Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.当代前列腺癌的Gleason分级：结合对实施2014年国际泌尿病理学会（ISUP）前列腺癌Gleason分级共识会议实际问题的讨论进行更新
Am J Surg Pathol. 2017 Apr;41(4):e1-e7. doi: 10.1097/PAS.0000000000000820.
2
Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.将三级 Gleason 5 模式纳入前列腺活检和前列腺切除术标本的定量 Gleason 分级中。
Eur Urol. 2018 May;73(5):674-683. doi: 10.1016/j.eururo.2017.01.015. Epub 2017 Jan 20.
3
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.前列腺腺癌的组织学分级可进一步优化：对来自金丝雀回顾性队列的1275例患者中个体结构模式的相对预后强度分析
Am J Surg Pathol. 2016 Nov;40(11):1439-1456. doi: 10.1097/PAS.0000000000000736.
4
Reporting intraductal carcinoma of the prostate: a plea for greater standardization.前列腺导管内癌的报告：呼吁更大程度的标准化。
Histopathology. 2017 Feb;70(3):504-507. doi: 10.1111/his.13081. Epub 2016 Nov 10.
5
Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.当代前列腺癌 Gleason 模式 4 的百分比和结构类型对根治性前列腺切除术预后的意义。
Am J Surg Pathol. 2016 Oct;40(10):1400-6. doi: 10.1097/PAS.0000000000000691.
6
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.《2016 年世界卫生组织泌尿系统及男性生殖器官肿瘤分类-第 B 部分：前列腺和膀胱肿瘤》。
Eur Urol. 2016 Jul;70(1):106-119. doi: 10.1016/j.eururo.2016.02.028. Epub 2016 Mar 17.
7
Differential Diagnosis of Intraductal Lesions of the Prostate.前列腺导管内病变的鉴别诊断
Am J Surg Pathol. 2016 Jun;40(6):e67-82. doi: 10.1097/PAS.0000000000000609.
8
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.2014年国际泌尿病理学会（ISUP）前列腺癌Gleason分级共识会议：分级模式的定义及新分级系统的建议
Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530.
9
Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death.Gleason 评分 3+5 或 5+3 与 4+4 前列腺癌：死亡风险。
Eur Urol. 2016 Jun;69(6):976-9. doi: 10.1016/j.eururo.2015.08.054. Epub 2015 Sep 19.
10
Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?Gleason评分5 + 3 = 8的前列腺癌：是否更像Gleason评分9的前列腺癌？
BJU Int. 2016 Jul;118(1):95-101. doi: 10.1111/bju.13239. Epub 2015 Aug 22.
Zotero 插件